Drug Profile
Research programme: glucokinase stimulants - Hua Medicine/Roche
Alternative Names: GKA programme - Hua Medicine/Roche; Glucokinase activator programme - Hua Medicine/Roche; RO 0281675Latest Information Update: 30 Oct 2013
Price :
$50
*
At a glance
- Originator Roche
- Developer Hua Medicine; Roche
- Class Acrylamides; Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus